🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
Investigate the effect of induction MEPFL chemotherapy followed by concurre...
Status
Completed
Location
Kaohsiung Medical University Hospital
Start Date
2003-08
Trial ID
NCT00201396
Treatments Being Tested
This phase I trial studies how well atezolizumab before and/or with standar...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-07
Trial ID
NCT03738228
Treatments Being Tested
The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)
Start Date
2019-12-01
Trial ID
NCT04250922
This is an international phase III trial, with a Bayesian design, incorpora...
Status
Recruiting
Location
Los Angeles County-USC Medical Center
Start Date
2017-05-12
Trial ID
NCT02305654
This randomized phase III trial is comparing the effectiveness of three adj...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2003-10-15
Trial ID
NCT00068692
Treatments Being Tested
This is a randomized, prospective, multicenter study....
Status
Completed
Location
Sichuan Cancer Hospital & Institute
Start Date
2014-09
Trial ID
NCT02399306
Treatments Being Tested
Concurrent chemoradiotherapy has been demonstrated a significant improvemen...
Status
Unknown
Location
Zhongnan Hospital of Wuhan University
Start Date
2013-05
Trial ID
NCT01889303
Treatments Being Tested
The goal of this study is to assess the safety and effectiveness of Dostarl...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-03-21
Trial ID
NCT06256588
Treatments Being Tested